EUVIMEDEUVIMED entdecken
Crossref

Sevrage tabagique au cours de la grossesse

V Peyronnet, A-L Le Faou, I Berlin

Revue des Maladies Respiratoires · 2024

DOI: 10.1016/j.rmr.2024.06.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revue des Maladies Respiratoires, 2024. Verfasst von V Peyronnet und 2 weiteren Autor:innen. Beteiligte Einrichtung: Service de gynécologue-obstétrique, hôpital Louis-Mourier, AP-HP, Colombes, France. Electronic address: violaine.peyronnet@aphp.fr. Hauptthemen laut MEDLINE: Pregnancy Complications, Smoking Cessation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 110 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Smoking during pregnancy is associated with negative pregnancy and perinatal health outcomes. Physiological and societal particularities can modify the smoking behavior of pregnant women. Pregnancy is a teachable moment for smoking cessation. Increased nicotine clearance may lead to exacerbated tobacco withdrawal symptoms and desire to smoke, which need to be taken into account when helping pregnant smokers to quit. Although most pregnant smokers try to quit on their own, 12% of pregnant women in France reported smoking in 2021 during the 3rd trimester of pregnancy. Health care professionals should screen for tobacco consumption and assess the level of addiction. Management of smoking cessation can be multidisciplinary, including non-pharmacological support such as counselling, behavioral support, financial reward contingent on abstinence, and medication (nicotine replacement therapies). Assessment and limitation of secondhand smoke exposure (SHS) is needed because SHS can also have negative maternal and fetal consequences. Management of relapse during the postpartum period is also to be anticipated; in 2021, it concerned 22.4% of women who had stopped smoking during pregnancy. While electronic cigarette use is increasing overall and among pregnant women who smoke (5.4 before pregnancy, 1.3% during the 3rd trimester in 2021), well-conducted smoking cessation studies are necessary to assess its benefits and potential risks in this specific group of smokers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy ComplicationsSmoking CessationFemaleHumansPregnancyFranceSmokingTobacco Smoke PollutionTobacco Use Cessation Devices

Stichwörter der Autor:innen

Effets pré- et postnatauxPre- and post-natal effectsSevrage tabagique pendant la grossesseSmoking cessation during pregnancySmoking during pregnancyTabagisme pendant la grossesse

Substanzen

Tobacco Smoke Pollution

Autor:innen und Institutionen

  • Service de gynécologue-obstétrique, hôpital Louis-Mourier, AP-HP, Colombes, France. Electronic address: violaine.peyronnet@aphp.fr.
  • Centre ambulatoire d'addictologie, hôpital européen Georges-Pompidou, centre - université Paris-Cité, AP-HP, Paris, France.
  • Département de pharmacologie médicale, hôpital Pitié-Salpêtrière, Sorbonne université, Paris, France.

Zitieren

APA

Peyronnet, V., Le Faou, A. L., & Berlin, I. (2024). Sevrage tabagique au cours de la grossesse. Revue des Maladies Respiratoires. https://doi.org/10.1016/j.rmr.2024.06.009

Vancouver

Peyronnet V, Le Faou AL, Berlin I. Sevrage tabagique au cours de la grossesse. Revue des Maladies Respiratoires. 2024. doi:10.1016/j.rmr.2024.06.009

BibTeX
@article{Peyronnet2024,
  author = {Peyronnet, V and Le Faou, A-L and Berlin, I},
  title = {Sevrage tabagique au cours de la grossesse},
  journal = {Revue des Maladies Respiratoires},
  year = {2024},
  doi = {10.1016/j.rmr.2024.06.009}
}
Kostenlos starten →